Výsledky vyhledávání
- 1.MACKOVÁ, J.; HAINZ, P.; KRYŠTOFOVÁ, J.; ROUBALOVÁ, K.; ŠŤASTNÁ-MARKOVÁ, M.; VANÍKOVÁ, Š.; MUSIL, J.; VYDRA, J.; NĚMEČKOVÁ, Š.G Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy. Leukemia research. 2023, vol. 130, no. July, art. no. 107314. ISSN 0145-2126.
- 2.NEMECKOVA, S.G; ALEXOVA-ZURKOVA, K.; HAINZ, P.; KRYSTOFOVA, J.; MACKOVA, J.; ROUBALOVA, K.; STASTNA-MARKOVA, M.; VRANA, M.; VYDRA, J. Non-mutated nucleophosmin 1 is recognized by the CD8+ T lymphocytes of an AML patient after the transplantation of hematopoietic stem cells from an HLA-haploidentical donor. Current oncology. 2022, vol. 29, no. 5, s. 2928-2934. ISSN 1198-0052.
- 3.PETRÁŠ, M.; LESNÝ, P.; MUSIL, J.; LIMBERKOVÁ, R.; PÁTÍKOVÁ, A.; JIRSA, M.; KRSEK, D.; BŘEZOVSKÝ, P.; KOLADIYA, A.; VANÍKOVÁ, Š.; MACKOVÁ, B.; JÍROVÁ, D.; KRIJT, M.; ET AL. Early immune response in mice immunized with a semi-split inactivated vaccine against SARS-CoV-2 containing S protein-free particles and subunit S protein. The bioRxiv preprint server. 2020, [November], art. no. 366641.
- 4.MACKOVÁ, J. In vitro generation of HCMV specific T-lymphocytes using IVT mRNA. [Předneseno: 10th international conference drug delivery systems nanotechnology for healthcare: progress in recombinant vaccines, molecular adjuvants and modern drug delivery systems. Telč, 28.5.-31.5.2017.].
- 5.MACKOVÁ, J.; ŽŮRKOVÁ, K.; MUSIL, J.; PÍSKOVÁ, L.; GABRIEL, P.; HAINZ, P.; NĚMEČKOVÁ, Š. In vitro generation of HCMV specific T-lymphocytes using dendritic cells electroporated with in-vitro transcribed mRNA. [Prezentováno: Third CRI-CIMT-EATI-AACR international cancer immunotherapy conference. Mainz/Frankfurt, 6.9.-9.9.2017.].
- 6.NĚMEČKOVÁ, Š.; BABIAROVÁ, K.; KRYŠTOFOVÁ, J.; MACKOVÁ, J.; ŠŤASTNÁ, M. Jak vývoj séroprevalence proti lidskému cytomegaloviru v Evropě v 21. století ovlivňuje léčbu pomocí transplantace hematopoietických kmenových buněk? [Předneseno: Kongres klinické mikrobiologie, infekčních nemocí a epidemiologie. Špindlerův Mlýn, 23.9.-25.9.2015.].
- 7.MACKOVA, J.; ZURKOVA, K.; SROLLER, V.; MUSIL, J.; BABIAROVA, K.; NEMECKOVA, S. In vitro generation of HCMV specific T-lymphocytes. Journal of clinical virology. 2015, vol. 70, no. S1, s. S116. ISSN 1386-6532.
- 8.BABIAROVA, K.; KRYSTOFOVA, J.; HAINZ, P.; STASTNA, M.; MACKOVA, J.; MUSIL, J.; SROLLER, V.; NEMECKOVA, S. Detection of anti-HCMV T cell response of potential recipients and donors in cellular immunotherapy of leukemic patients after transplantation of hematopoietic stem cells. [Prezentováno: 17th Annual Meeting of the European Society for Clinical Virology. Praha, 28.9.-1.10.2014.].
- 9.NĚMEČKOVÁ, Š.; BABIAROVÁ, K.; HAINZ, P.; KRYŠTOFOVÁ, J.; MACKOVÁ, J.; ŠROLLER, V.; ŠŤASTNÁ, M. Study of anti-HCMV T cell responses and CXCL9 production of patients after transplantation of hematopoetic stem cells. [Prezentováno: 16th Biennal Meeting of the European Society for Immunodeficiencies ESID. Praha, 29.10.-1.11.2014.].
- 10.GABRIEL, P.; NEMECKOVA, S.; SMAHEL, M.; BABIAROVA, K.; ZURKOVA, K.; MACKOVA, J.; KRYSTOFOVA, J.; HAINZ, P.; KUTINOVA, L.; INDROVA, M. Study of the effect of immunological adjuvants on experimental treatment of HPV-induced tumors by recombinant VACV and DNA vaccines. [Prezentováno: 17th Annual Meeting of the European Society for Clinical Virology. Praha, 28.9.-1.10.2014.].